Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

Clinical trial NCT00061542 · COMPLETED

Trial details

NCT number: NCT00061542
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2003-01-01
Primary completion: 2006-11-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.